Emergent BioSolutions Secures $29 Million in Orders From International Government Partner-March 2024-www.financetom.com

Emergent BioSolutions Secures $29 Million in Orders From International Government Partner

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Emergent BioSolutions Secures $29 Million in Orders From International Government Partner

Sep 21, 2025 1:24 AM

09:08 AM EDT, 09/19/2025 (MT Newswires) -- Emergent BioSolutions ( EBS ) said Friday it has secured $29 million in purchase orders from an international government partner.

The orders cover medical countermeasures for smallpox, anthrax and botulism threats, the company said.

Under the deal, Emergent BioSolutions ( EBS ) said it will receive about $26 million in 2025.

Previous page： BRIEF-Coeptis Therapeutics Executes Binding Letter of Intent to Acquire Ai-powered Marketing Solutions for Biotech, Pharmaceutical and Other Industries Next page： Corbus Pharmaceuticals' CRB-701 Gets FDA Fast Track Designation for Treatment of Cervical Cancer

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

BRIEF-Coeptis Therapeutics Executes Binding Letter of Intent to Acquire Ai-powered Marketing Solutions for Biotech, Pharmaceutical and Other Industries

Dec 3, 2024

Dec 3 (Reuters) - Coeptis Therapeutics Holdings Inc ( COEP ) : * COEPTIS THERAPEUTICS EXECUTES BINDING LETTER OF INTENT TO ACQUIRE AI-POWERED MARKETING SOLUTIONS FOR BIOTECH, PHARMACEUTICAL AND OTHER INDUSTRIES Source text: Further company coverage: ...

Corbus Pharmaceuticals' CRB-701 Gets FDA Fast Track Designation for Treatment of Cervical Cancer

Dec 3, 2024

08:59 AM EST, 12/03/2024 (MT Newswires) -- Corbus Pharmaceuticals Holdings ( CRBP ) said Tuesday that CRB-701 has received fast track designation from the US Food and Drug Administration for the treatment of relapsed or refractory metastatic cervical cancer. The company said the designation aims to facilitate the development and hasten the review of drugs that have the potential to...

Market Chatter: Vale to Keep 2025 Iron Ore Production Steady

Dec 3, 2024

08:54 AM EST, 12/03/2024 (MT Newswires) -- Vale (VALE) is looking to keep its iron ore production levels little changed next year at 325 million to 335 million metric tons, Bloomberg News reported, citing disclosures for the company's investor event on Tuesday. Vale expects to produce about 328 million tons this year, the report said. (Market Chatter news is derived...

Exclusive-Worldline attracts early stage interest from private equity firms, sources say

Dec 3, 2024

LONDON (Reuters) -French payments group Worldline has attracted early stage takeover interest from private equity firms, as it grapples with a falling share price, profit warnings and leadership change, five people with knowledge of the matter said. Bain Capital is among private equity firms that have been in the initial stages of evaluating a possible bid for Worldline, two of...